(Q62024878)
Statements
A Prospective, Multicenter Observational Trial Assessing the Safety and Efficacy of Gammanorm® in Autoimmune Diseases (English)
0 references
23 November 2016
0 references
23 November 2020
0 references
80
0 references
18 year
0 references